Research on molecular technologies, biomarkers present in body fluids and cancer biomarkers has led to the development of diagnostic procedures such as liquid biopsy. The test analyzes samples of biological fluids using techniques such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) to detect mutations. The latest market intelligence report published by BIS research examines the attractiveness of the global liquid biopsy industry with Porter’s Five Forces and also includes the market share analysis.